Skip to main content
. 2021 Nov 10;9:293–299. doi: 10.1016/j.xjon.2021.11.003

Figure 2.

Figure 2

Trial design and flow chart of the Preoperative Anti-PD-1 Antibody combined with Chemoradiotherapy for Locally Advanced Squmous Cell Carcinoma of Esophageus-2 trial. ESCC, Esophageal squamous cell carcinoma; AUC, area under the curve; pCR, pathologic complete response; DFS, disease-free survival; OS, overall survival; AEs, adverse events.